COMP <GO>
BNTC vs PRLD // NET PROFIT MARGIN
Benitec Biopharma Inc. (NASDAQ) VS. Prelude Therapeutics Incorporated (NASDAQ) • 15-METRIC TALLY: BNTC 1
— PRLD 3
■ METRIC PARITY
LAST: $8.49 (-2.86%) • MKT CAP: $304.9M
net-margins
—
LAST: $3.84 (-1.03%) • MKT CAP: $309.6M
net-margins
-60.00%
15-METRIC INSTITUTIONAL SIDE-BY-SIDE SCORECARD (BNTC VS. PRLD)
EMERALD CELL = QUANTITATIVE EDGE
| INSTITUTIONAL METRIC | BNTC | PRLD | SPREAD (A - B) | ADVANTAGE | DEDICATED URL |
|---|---|---|---|---|---|
| Gross Profit Margin | — | — | — | TIE | /gross-margins <GO> |
| Return on Invested Capital (ROIC) | -35.00% | -35.00% | 0.00 | TIE | /roic <GO> |
| EV/EBITDA & P/E Valuation | — | — | — | TIE | /valuation <GO> |
| Free Cash Flow Yield | -7.66% | -17.23% | +9.57 | BNTC | /fcf-yield <GO> |
| Operating Margin | — | -60.00% | — | TIE | /operating-margins <GO> |
| Net Profit Margin ACTIVE | — | -60.00% | — | TIE | /net-margins <GO> |
| Revenue Growth (YoY) | — | 73.40% | — | TIE | /revenue-growth <GO> |
| Dividend Yield & FCF Payout Safety | 0.00% | 0.00% | 0.00 | TIE | /dividend-safety <GO> |
| Altman Z-Score & Debt/Equity | — | — | — | TIE | /balance-sheet <GO> |
| Piotroski F-Score Quality | 2/9 | 4/9 | -2.00 | PRLD | /piotroski-score <GO> |
| Options Implied Move & Put/Call Skew | — | — | — | TIE | /options-implied-move <GO> |
| RSI-14 & 200D SMA Momentum | 42.9 | 48.9 | -6.00 | PRLD | /rsi-technicals <GO> |
| 10Y Yield & FRED Macro Beta | — | — | — | TIE | /macro-sensitivity <GO> |
| Forward P/E Multiple | — | — | — | TIE | /forward-pe <GO> |
| Enterprise Scale & Market Cap | $304.9M | $309.6M | -$4.7M | PRLD | /market-cap <GO> |
5-YEAR HISTORICAL XBRL REVENUE & MARGIN TRAJECTORY SEC FORM 10-K FY
| FISCAL YEAR | BNTC REV | PRLD REV | BNTC GROSS % | PRLD GROSS % | BNTC FCF | PRLD FCF |
|---|---|---|---|---|---|---|
| FY 2025 | $116.9M | $12.1M | — | — | -$23.6M | -$56.4M |
| FY 2024 | $63.0M | $7.0M | — | — | -$19.6M | -$103.7M |
| FY 2023 | $53.4M | $370.4M | — | — | -$18.0M | -$107.1M |
FRED MACRO REGIME CORRELATION COMPARISON PEARSON r
BNTC // BETA —
PRLD // BETA —